Differential β2-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines-Reference-Cited by-同舟云学术

Differential β2-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines

Published:2014-10-18 Issue:20 Volume:5 Page:10058-10069
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Gargiulo Lucía¹,Copsel Sabrina¹²,Rivero Ezequiel M.¹,Galés Céline³,Sénard Jean-Michel³,Lüthy Isabel A.¹,Davio Carlos²,Bruzzone Ariana¹

Affiliation:

1. Instituto de Biología y Medicina Experimental-CONICET. Vuelta de Obligado 2490. C1428ADN, CABA, Argentina

2. Laboratorio de Farmacología de Receptores. Departamento de Farmacología. Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. Junin 956 (1113) CABA, Argentina

3. Institut des Maladies Métaboliques et Cardiovasculaires. Institut National de la Santé et de la Recherche Médicale. U1048, Université Toulouse III Paul Sabatier, F-31432 Toulouse, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nerve-tumor crosstalk in tumor microenvironment: From tumor initiation and progression to clinical implications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. β2-Adrenoceptor Activation Favor Acquisition of Tumorigenic Properties in Non-Tumorigenic MCF-10A Breast Epithelial Cells;Cells;2024-01-30

3. Inside the Biology of the β3-Adrenoceptor;Biomolecules;2024-01-29

4. The stress connection in cancer: the adrenergic fuelling of breast tumors;Current Opinion in Physiology;2023-12

5. The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models;Cancer Chemotherapy and Pharmacology;2023-09-19